Loading…
BDH Industries (BSE 524828)₹414.55−2.46%Pharmaceuticals
BDH Industries is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 22.1 against a peer median of 22.1, and ROCE of 19.9% against a peer median of 12.1%, and latest-quarter sales growth of 62.8% against a peer median of 18.7%. By market cap it is #5 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ambalal Sarabhai Enterprises | 276 | 20.6 | 12.1 | 12.3 | 0.36 | 0.0 | 202 | 18 | 7.9 | −51.5 | vs BSE 524828 |
| Astal Laboratories | 263 | 17.3 | 9.0 | 8.0 | 0.15 | 0.0 | 249 | 15 | — | — | vs BSE 524828 |
| Everest Organics | 255 | 44.6 | 12.0 | 7.6 | 0.66 | 0.0 | 196 | 6 | 19.2 | −9.7 | vs BSE 524828 |
| Sat Kartar Life | 245 | 14.2 | 36.0 | 26.5 | 0.04 | 0.5 | 201 | 17 | 26.7 | 28.4 | vs BSE 524828 |
| BDH Industries | 240 | 22.1 | 19.9 | 14.8 | 0.03 | 1.2 | 96 | 11 | 62.8 | 15.6 | — |
| Zenotech Laboratories | 238 | — | 4.6 | −1.2 | 0.00 | 0.0 | 44 | −1 | 10.2 | −145.0 | vs BSE 524828 |
| Accretion Nutraveda | 237 | 47.2 | 27.8 | 25.1 | 0.12 | 0.0 | 34 | 5 | 80.4 | 56.1 | vs BSE 524828 |
| Accretion Pharmaceuticals | 225 | 23.3 | 28.9 | 27.6 | 0.23 | 0.0 | 89 | 10 | 18.2 | 13.9 | vs BSE 524828 |
| Gennex Laboratories | 218 | 11.2 | 11.0 | 9.2 | 0.36 | 0.0 | 173 | 21 | 16.5 | −6.8 | vs BSE 524828 |
| Sanjivani Paranteral | 214 | 28.8 | 18.0 | 15.6 | 0.30 | 0.3 | 69 | 7 | 33.3 | 44.2 | vs BSE 524828 |
| Kerala Ayurveda | 212 | — | −10.0 | −161.1 | 7.83 | 0.0 | 131 | −16 | 15.9 | −500.5 | vs BSE 524828 |
| Peer median | 238 | 22.1 | 12.1 | 12.3 | 0.23 | 0.0 | 131 | 10 | 18.7 | 3.6 |
Listed companies closest to BDH Industries in Pharmaceuticals include Ambalal Sarabhai Enterprises, Astal Laboratories, Everest Organics, Sat Kartar Life, Zenotech Laboratories, Accretion Nutraveda, Accretion Pharmaceuticals, Gennex Laboratories.
Ambalal Sarabhai Enterprises, with a market cap of ₹276 Cr.
BDH Industries trades at a P/E of 22.1; the median of its peer set is 22.1. A P/E above or below the median is a description, not a judgement on value.
BDH Industries' return on capital employed is 19.9%, above the peer median of 12.1%.